Abstract: An oral drug delivery device (100) comprising a housing (102) having a longitudinal axis (104) and extending from a first end to a second end, a first attachment part (110) having a first distal end (112) and a first proximal end (114), the first attachment part connected within the housing and configured to deliver an active drug substance (154), and an actuator (116) engaged with the first attachment part and configured to rotate the first attachment part about a first rotation axis (118), wherein the first rotation axis optionally forms an angle larger than 45 degrees with the longitudinal axis.

Abstract: The present disclosure relates to a delivery device (2) capable of delivering payload to an internal surface of a subject. In some embodiments, the delivery device may deliver payload to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: A drug delivery device comprising a first body part, a second body part, a first attachment part connected to the first body part and having a first distal end and a second attachment part connected to the second body part and having a second distal end. and an actuator mechanism configured to rotate one of the first body part and/or the second body part about a central axis. The drug delivery device is configured to transition from an initial configuration to an attachment configuration, and from the attachment configuration to a release configuration.

Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: A drug delivery device comprising a central axis extending from a first longitudinal end of the drug delivery device to a second longitudinal end of the drug delivery device, a first body part, a second body part, an attachment part connected to the first body part, and an actuator mechanism configured to rotate one of the first body part and/or the second body part, wherein the actuator mechanism is located more towards the first longitudinal end than the second longitudinal end along the central axis.

Abstract: A high-dose drug delivery device comprising a first body part, a second body part, an internal chamber within the first body part, an actuator mechanism configured to rotate at least one of the first body part or the second body part with respect to one another about a central axis of the high-dose drug delivery device, a first attachment part in communication with the internal chamber, and an injector mechanism configured to apply pressure on the internal chamber during or after rotation of the first body part or the second body part with respect to one another.

Abstract: A drug delivery device comprising, a first body part, an attachment part attached to the first body part, a second body part, an aperture in the first body part and/or the second body part, an actuator mechanism configured to store energy and convert the stored energy to kinetic energy via movement of the first body part or the second body part, and a locking system configured to prevent the actuator mechanism from converting the stored energy to the kinetic energy.

Abstract: A drug delivery device having a central axis, the drug delivery device comprising a first body part, a second body part, an actuator mechanism configured to rotate at least one of the first body part or the second body part with respect to one another about the central axis, and a first attachment part comprising a connector component and a first spike component, the connector component connected to the first body part and the first spike component releasably connected to the connector component.

Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: A drug delivery device having a central axis, the drug delivery device comprising a first body part, a second body part, an attachment part; and an actuator mechanism configured to rotate the first body part in relation to the second body part about a primary axis of the drug delivery device, wherein the drug delivery device comprises only a single attachment part.

Abstract: A drug delivery device having an axis, the drug delivery device comprising a carrier and an insert, the carrier comprising a first body part having a first recess, a first attachment part attached to the first body part and having a first distal end, a second body part having a second recess an actuator mechanism configured to rotate at least one of the first body part or the second body part with respect to one another about the axis, and an insert configured to be inserted and fixed in the second recess, the insert comprising a second attachment part and an insert body with an insert recess, the second attachment part having a second distal end.

Abstract: A drug delivery device having a central axis, the drug delivery device comprising: a first body part; a first attachment part attached to the first body part and having a first distal end; a second attachment part having a second distal end; and an actuator mechanism configured to move the first distal end towards the second distal end.

Abstract: The present disclosure relates to a delivery device (2) capable of delivering payload to an internal surface of a subject. In some embodiments, the delivery device may deliver payload to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.

Abstract: The present invention provides immediate release pharmaceutical compositions for oral administration that are resistant to abuse.

Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.

Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.

Abstract: The present invention provides immediate release pharmaceutical compositions for oral administration that are resistant to abuse.